Literature DB >> 11932412

New insights into the spring-loaded conformational change of influenza virus hemagglutinin.

Jennifer A Gruenke1, R Todd Armstrong, William W Newcomb, Jay C Brown, Judith M White.   

Abstract

Influenza virus hemagglutinin undergoes a conformational change in which a loop-to-helix "spring-loaded" conformational change forms a coiled coil that positions the fusion peptide for interaction with the target bilayer. Previous work has shown that two proline mutations designed to disrupt this change disrupt fusion but did not determine the basis for the fusion defect. In this work, we made six additional mutants with single proline substitutions in the region that undergoes the spring-loaded conformational change and two additional mutants with double proline substitutions in this region. All double mutants were fusion inactive. We analyzed one double mutant, F63P/F70P, as an example. We observed that F63P/F70P undergoes key low-pH-induced conformational changes and binds tightly to target membranes. However, limited proteolysis and electron microscopy observations showed that the mutant forms a coiled coil that is only approximately 50% the length of the wild type, suggesting that it is splayed in its N-terminal half. This work further supports the hypothesis that the spring-loaded conformational change is necessary for fusion. Our data also indicate that the spring-loaded conformational change has another role beyond presenting the fusion peptide to the target membrane.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11932412      PMCID: PMC155089          DOI: 10.1128/jvi.76.9.4456-4466.2002

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  32 in total

1.  N- and C-terminal residues combine in the fusion-pH influenza hemagglutinin HA(2) subunit to form an N cap that terminates the triple-stranded coiled coil.

Authors:  J Chen; J J Skehel; D C Wiley
Journal:  Proc Natl Acad Sci U S A       Date:  1999-08-03       Impact factor: 11.205

2.  Amino acid sequence requirements of the transmembrane and cytoplasmic domains of influenza virus hemagglutinin for viable membrane fusion.

Authors:  G B Melikyan; S Lin; M G Roth; F S Cohen
Journal:  Mol Biol Cell       Date:  1999-06       Impact factor: 4.138

3.  Structure of the hemagglutinin precursor cleavage site, a determinant of influenza pathogenicity and the origin of the labile conformation.

Authors:  J Chen; K H Lee; D A Steinhauer; D J Stevens; J J Skehel; D C Wiley
Journal:  Cell       Date:  1998-10-30       Impact factor: 41.582

4.  The central proline of an internal viral fusion peptide serves two important roles.

Authors:  S E Delos; J M Gilbert; J M White
Journal:  J Virol       Date:  2000-02       Impact factor: 5.103

5.  Enhancement of transfection efficiency by protamine in DDAB lipid vesicle-mediated gene transfer.

Authors:  J You; M Kamihira; S Iijima
Journal:  J Biochem       Date:  1999-06       Impact factor: 3.387

6.  Membrane perturbation and fusion pore formation in influenza hemagglutinin-mediated membrane fusion. A new model for fusion.

Authors:  P Bonnafous; T Stegmann
Journal:  J Biol Chem       Date:  2000-03-03       Impact factor: 5.157

7.  A mechanism of protein-mediated fusion: coupling between refolding of the influenza hemagglutinin and lipid rearrangements.

Authors:  M M Kozlov; L V Chernomordik
Journal:  Biophys J       Date:  1998-09       Impact factor: 4.033

8.  The ectodomain of HA2 of influenza virus promotes rapid pH dependent membrane fusion.

Authors:  R F Epand; J C Macosko; C J Russell; Y K Shin; R M Epand
Journal:  J Mol Biol       Date:  1999-02-19       Impact factor: 5.469

9.  Evidence that the transition of HIV-1 gp41 into a six-helix bundle, not the bundle configuration, induces membrane fusion.

Authors:  G B Melikyan; R M Markosyan; H Hemmati; M K Delmedico; D M Lambert; F S Cohen
Journal:  J Cell Biol       Date:  2000-10-16       Impact factor: 10.539

10.  Specific single or double proline substitutions in the "spring-loaded" coiled-coil region of the influenza hemagglutinin impair or abolish membrane fusion activity.

Authors:  H Qiao; S L Pelletier; L Hoffman; J Hacker; R T Armstrong; J M White
Journal:  J Cell Biol       Date:  1998-06-15       Impact factor: 10.539

View more
  27 in total

1.  A new class of receptor for herpes simplex virus has heptad repeat motifs that are common to membrane fusion proteins.

Authors:  Aleida Perez; Qing-Xue Li; Pilar Perez-Romero; Gregory Delassus; Santiago R Lopez; Sarah Sutter; Ning McLaren; A Oveta Fuller
Journal:  J Virol       Date:  2005-06       Impact factor: 5.103

2.  Spring-loaded heptad repeat residues regulate the expression and activation of paramyxovirus fusion protein.

Authors:  Laura E Luque; Charles J Russell
Journal:  J Virol       Date:  2007-01-24       Impact factor: 5.103

3.  pH-dependence of intermediate steps of membrane fusion induced by the influenza fusion peptide.

Authors:  Ding-Kwo Chang; Shu-Fang Cheng
Journal:  Biochem J       Date:  2006-06-15       Impact factor: 3.857

Review 4.  Modulation of the pH Stability of Influenza Virus Hemagglutinin: A Host Cell Adaptation Strategy.

Authors:  Santiago Di Lella; Andreas Herrmann; Caroline M Mair
Journal:  Biophys J       Date:  2016-06-07       Impact factor: 4.033

5.  Structural characterization of an early fusion intermediate of influenza virus hemagglutinin.

Authors:  Rui Xu; Ian A Wilson
Journal:  J Virol       Date:  2011-03-02       Impact factor: 5.103

6.  Capturing Spontaneous Membrane Insertion of the Influenza Virus Hemagglutinin Fusion Peptide.

Authors:  Javier L Baylon; Emad Tajkhorshid
Journal:  J Phys Chem B       Date:  2015-06-08       Impact factor: 2.991

7.  A histidine residue of the influenza virus hemagglutinin controls the pH dependence of the conformational change mediating membrane fusion.

Authors:  Caroline M Mair; Tim Meyer; Katjana Schneider; Qiang Huang; Michael Veit; Andreas Herrmann
Journal:  J Virol       Date:  2014-09-03       Impact factor: 5.103

8.  Stabilization of the soluble, cleaved, trimeric form of the envelope glycoprotein complex of human immunodeficiency virus type 1.

Authors:  Rogier W Sanders; Mika Vesanen; Norbert Schuelke; Aditi Master; Linnea Schiffner; Roopa Kalyanaraman; Maciej Paluch; Ben Berkhout; Paul J Maddon; William C Olson; Min Lu; John P Moore
Journal:  J Virol       Date:  2002-09       Impact factor: 5.103

Review 9.  V-ATPase functions in normal and disease processes.

Authors:  Ayana Hinton; Sarah Bond; Michael Forgac
Journal:  Pflugers Arch       Date:  2007-11-20       Impact factor: 3.657

10.  Architecture of a nascent viral fusion pore.

Authors:  Kelly K Lee
Journal:  EMBO J       Date:  2010-02-18       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.